Global Assets Advisory LLC Purchases 4,864 Shares of Stryker Corporation (NYSE:SYK)

Global Assets Advisory LLC raised its stake in Stryker Corporation (NYSE:SYK - Free Report) by 188.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,446 shares of the medical technology company's stock after acquiring an additional 4,864 shares during the period. Global Assets Advisory LLC's holdings in Stryker were worth $2,665,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the stock. Mascoma Wealth Management LLC increased its holdings in Stryker by 22.7% during the 4th quarter. Mascoma Wealth Management LLC now owns 146 shares of the medical technology company's stock valued at $53,000 after purchasing an additional 27 shares in the last quarter. Lindbrook Capital LLC grew its holdings in shares of Stryker by 2.0% during the fourth quarter. Lindbrook Capital LLC now owns 1,407 shares of the medical technology company's stock worth $507,000 after purchasing an additional 28 shares during the last quarter. Continuum Advisory LLC grew its holdings in shares of Stryker by 5.8% during the first quarter. Continuum Advisory LLC now owns 532 shares of the medical technology company's stock worth $198,000 after purchasing an additional 29 shares during the last quarter. United Community Bank increased its stake in shares of Stryker by 3.4% in the fourth quarter. United Community Bank now owns 904 shares of the medical technology company's stock valued at $325,000 after buying an additional 30 shares in the last quarter. Finally, Ironwood Investment Counsel LLC raised its holdings in shares of Stryker by 0.9% in the fourth quarter. Ironwood Investment Counsel LLC now owns 3,323 shares of the medical technology company's stock valued at $1,196,000 after buying an additional 30 shares during the last quarter. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. Roth Mkm increased their price objective on shares of Stryker from $405.00 to $456.00 and gave the stock a "buy" rating in a report on Friday, May 2nd. The Goldman Sachs Group set a $422.00 target price on shares of Stryker in a research note on Tuesday, March 4th. Citigroup reissued a "buy" rating and set a $455.00 price target (up from $443.00) on shares of Stryker in a research note on Thursday, May 22nd. Wall Street Zen raised shares of Stryker from a "hold" rating to a "buy" rating in a report on Saturday, June 14th. Finally, JMP Securities restated a "market perform" rating on shares of Stryker in a research report on Monday, May 5th. Four investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $427.30.

Insider Transactions at Stryker

In related news, Director Ronda E. Stryker sold 200,000 shares of the business's stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total value of $75,392,000.00. Following the completion of the transaction, the director now directly owns 3,417,326 shares in the company, valued at approximately $1,288,195,208.96. The trade was a 5.53% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 5.20% of the stock is currently owned by insiders.

Stryker Trading Up 1.5%

Stryker stock traded up $5.90 during midday trading on Wednesday, hitting $392.36. 1,915,995 shares of the stock were exchanged, compared to its average volume of 1,337,858. The stock has a market capitalization of $149.76 billion, a PE ratio of 53.02, a P/E/G ratio of 2.86 and a beta of 0.91. The company has a fifty day simple moving average of $376.26 and a two-hundred day simple moving average of $375.19. The company has a quick ratio of 1.00, a current ratio of 1.64 and a debt-to-equity ratio of 0.69. Stryker Corporation has a 52 week low of $314.93 and a 52 week high of $406.19.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share for the quarter, topping analysts' consensus estimates of $2.73 by $0.11. Stryker had a net margin of 12.31% and a return on equity of 23.74%. The company had revenue of $5.87 billion for the quarter, compared to analysts' expectations of $5.68 billion. During the same period last year, the firm posted $2.50 earnings per share. The business's quarterly revenue was up 11.9% compared to the same quarter last year. Equities research analysts anticipate that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Monday, June 30th will be issued a $0.84 dividend. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.36 annualized dividend and a dividend yield of 0.86%. Stryker's dividend payout ratio (DPR) is currently 45.41%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.